<html>
<head>
<title>Section 126-Z:2 Availability of Investigational Drugs, Biological Products, or Devices;  Costs;  Coverage.</title>
<!-- Hide metadata
<titlename>TITLE X PUBLIC HEALTH</titlename>
<chapter>CHAPTER 126-Z TERMINAL PATIENTS' RIGHT TO TRY ACT</chapter>
<sectiontitle>Section 126-Z:2 Availability of Investigational Drugs, Biological Products, or Devices;  Costs;  Coverage.</sectiontitle>
-->
</head>
<body>
<center><h1>TITLE X<br>PUBLIC HEALTH</h1></center>
<center><h2>CHAPTER 126-Z<br>TERMINAL PATIENTS' RIGHT TO TRY ACT</h2></center>
<center><h3>Section 126-Z:2</h3></center>
&nbsp;&nbsp;&nbsp;<b> 126-Z:2 Availability of Investigational Drugs, Biological Products, or Devices;  Costs;  Coverage. &#150;</b>
<codesect>
<br>
&nbsp&nbsp&nbsp
I. A manufacturer of an investigational drug, biological product, or device may make available an investigational drug, biological product, or device to eligible patients pursuant to this chapter.  A manufacturer may:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) Require an eligible patient to pay the costs of or associated with the manufacture of the investigational drug, biological product, or device.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(c) Require an eligible patient to participate in data collection relating to the use of the investigational drug, biological product, or device.
<br>
&nbsp&nbsp&nbsp
II. This chapter shall not require a health care insurer or any state agency to provide coverage for the cost of any investigational drug, biological product, or device.
<br>
&nbsp&nbsp&nbsp
III. Nothing in this chapter shall require the manufacturer of an investigational drug, biological product, or device to include an eligible patient in a particular clinical trial or study.
</codesect>
<sourcenote>
<p><b>Source.</b>  2016, 206:2, eff. June 6, 2016.</p>
</sourcenote>
</body>
</html>
